Defective nitric oxide production by alveolar macrophages during Pneumocystis pneumonia

Mark E Lasbury1, Chung-Ping Liao, Chadi A Hage

  • 1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202-5113, USA.

Insights

Nitric oxide (NO) is toxic to Pneumocystis organisms and aids in fighting infection. However, alveolar macrophages produce less NO during Pneumocystis pneumonia due to defective inducible nitric oxide synthase dimerization.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Pneumocystis pneumonia (PCP) is a serious opportunistic infection.
  • Nitric oxide (NO) plays a role in host defense mechanisms.
  • Alveolar macrophages (AMs) are key immune cells in the lungs.

Purpose of the Study:

  • To investigate the effect of NO on Pneumocystis (Pc) organisms.
  • To determine the role of NO in combating Pc infection.
  • To examine NO production by AMs during PCP.

Main Methods:

  • In vitro culture of Pc organisms with NO.
  • Inhibition of NO production in rats using a nitric oxide synthase inhibitor.
  • Measurement of NO concentrations in bronchoalveolar lavage fluid.
  • Analysis of inducible nitric oxide synthase (iNOS) expression and dimerization in AMs.

Main Results:

  • NO demonstrated toxicity and inhibited Pc proliferation in culture.
  • Inhibition of NO production accelerated Pc infection in immunocompetent rats.
  • Reduced NO levels and impaired NO production by AMs were observed in immunosuppressed, Pc-infected animals.
  • While iNOS expression was high, iNOS dimerization was defective in AMs from infected animals, with calmodulin identified as a crucial cofactor for dimerization.

Conclusions:

  • NO is crucial for host defense against Pneumocystis infections.
  • Defective iNOS dimerization in AMs impairs NO production during PCP.
  • Restoring iNOS dimerization may be a therapeutic target for PCP.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...